Richard Becker, MD
Staff Affiliate - OtherCards
About
Research
Publications
2025
Immune checkpoint inhibitors and cardiovascular toxicity: immunology, pathophysiology, diagnosis, and management
Becker R. Immune checkpoint inhibitors and cardiovascular toxicity: immunology, pathophysiology, diagnosis, and management. Journal Of Thrombosis And Thrombolysis 2025, 1-24. PMID: 40673965, DOI: 10.1007/s11239-025-03146-7.Peer-Reviewed Original ResearchImmune checkpoint inhibitorsCytotoxic T-lymphocyte antigen (CTLA)-4Discontinuation of immune checkpoint inhibitorsProgrammed cell death (PD)-1Immune checkpoint inhibitor myocarditisImmune-related adverse eventsHigh-dose corticosteroidsSteroid-refractory casesLigand PD-L1Advanced lung cancerCheckpoint inhibitorsCombination immunotherapyPD-L1Immunosuppressive therapyCT angiogramAtrial arrhythmiasImproved survivalCardiac MRICardiovascular toxicityVascular toxicityAdverse eventsAutoimmune biomarkersLung cancerPhysical findingsCardiotoxic effectsCorrection to: C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes
Andersen T, Ueland T, Lakic T, Åkerblom A, Bertilsson M, Aukrust P, Michelsen A, James S, Becker R, Storey R, Wallentin L, Siegbahn A, Kontny F, Investigators F. Correction to: C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. Arteriosclerosis Thrombosis And Vascular Biology 2025, 45: e336-e336. PMID: 40560990, DOI: 10.1161/atv.0000000000000187.Peer-Reviewed Original ResearchA Multi-Omics Approach to Defining the Target Organ Injury in Youth with Primary Hypertension
Ananthamohan K, Brady T, Arif M, Daniels S, Falkner B, Ferguson M, Flynn J, Hanevold C, Hooper S, Ingelfinger J, Lande M, Martin L, Meyers K, Mitsnefes M, Rosner B, Samuels J, Kuffel G, Zilliox M, Becker R, Urbina E, Sadayappan S. A Multi-Omics Approach to Defining the Target Organ Injury in Youth with Primary Hypertension. Journal Of Molecular And Cellular Cardiology Plus 2025, 12: 100339. DOI: 10.1016/j.jmccpl.2025.100339.Peer-Reviewed Original Research
2024
Bridging the gap: strategies for recognizing and managing post-COVID conditions
Khan M, Becker R. Bridging the gap: strategies for recognizing and managing post-COVID conditions. Frontiers In Medicine 2024, 11: 1395420. PMID: 39635598, PMCID: PMC11615723, DOI: 10.3389/fmed.2024.1395420.Peer-Reviewed Original ResearchQuality of lifePost-COVID conditionsTargeted interventionsPrevalence of chronic conditionsStandardized screening toolPatient-centered approachPrevalence of post-COVID conditionImprove quality of lifeHigh-risk individualsPsychosocial healthHealthcare providersChronic conditionsCardiovascular healthEarly diagnosisImprove qualityScreening toolPeripheral vascular diseaseCommunity leadersComorbid conditionsDevelopment of screening strategiesPersistent symptomsCost-effective screening approachHealthAffected individualsInterventionPATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study
Becker R, Harnett B, Wayne D, Mardis R, Meganathan K, Steen D. PATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study. Clinical Research In Cardiology 2024, 114: 497-506. PMID: 39527276, DOI: 10.1007/s00392-024-02572-6.Peer-Reviewed Original ResearchStable cardiovascular diseaseAmbulatory clinic visitsAmbulatory clinic settingCardiovascular diseaseS-ECGClinical research coordinatorsClinical indicationsClinic visitsResearch coordinatorsValvular heart diseaseCoronary artery diseaseMedical practiceParticipantsEssential hypertensionClinical settingLead placementAtrial fibrillationHeart diseaseHeart failureTreatment decisionsArtery diseaseST-TElectrocardiographyBaselineHeart rhythmSystolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents
Hooper S, Lande M, Flynn J, Hanevold C, Meyers K, Samuels J, Becker R, Daniels S, Falkner B, Ferguson M, Ingelfinger J, Martin L, Mitsnefes M, Khoury P, Seo J, Urbina E. Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents. Hypertension 2024, 81: 2444-2453. PMID: 39291378, PMCID: PMC11578784, DOI: 10.1161/hypertensionaha.124.22834.Peer-Reviewed Original ResearchParent ratings of executive functioningRatings of executive functionSystolic blood pressureLow nonverbal IQCardiovascular risk factorsNonverbal IQVerbal attentionCardiovascular healthExecutive functionParent ratingsRisk factorsAssociated with parent ratingsAmbulatory systolic blood pressureHealth risk indicatorsNeurocognitive outcomesCross-sectional studyAcademic medical centerAssociated with neurocognitionHigh school degreeElevated systolic blood pressureAssociated with neurocognitive outcomesBlood pressureBlood pressure measurementsClinical carePrimary exposureThe COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management
Becker R, Tantry U, Khan M, Gurbel P. The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management. Journal Of Thrombosis And Thrombolysis 2024, 58: 15-49. PMID: 39179952, PMCID: PMC11762605, DOI: 10.1007/s11239-024-03028-4.Peer-Reviewed Original ResearchNeutrophil extracellular trapsMild to moderate illnessHost immunoinflammatory responseOptimal patient managementSARS-CoV-2SARS-CoV-2 infectionEndothelial cell inflammationVascular endothelial cellsSurveillance modalitiesClinical featuresOrgan injuryImmunoinflammatory responseMicrovascular thrombosisInflammatory signatureAtherothrombotic phenotypeCirculating monocytesChronic phasePatient managementVascular eventsAcute phaseExtracellular trapsCritical illnessThrombosisEndothelial cellsMedical literatureThe journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting
Becker R. The journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting. Journal Of Thrombosis And Thrombolysis 2024, 57: 1103-1108. PMID: 38980568, DOI: 10.1007/s11239-024-03012-y.Peer-Reviewed Original ResearchMilvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome
Tantry U, Raghavakurup L, Becker R, Singh S, Bliden K, Gurbel P. Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome. Expert Opinion On Pharmacotherapy 2024, 25: 1271-1280. PMID: 39072402, DOI: 10.1080/14656566.2024.2385062.Peer-Reviewed Original ResearchConceptsAcute coronary syndromeCoronary syndromeElevated risk of bleedingPathological thrombosisTreatment of acute coronary syndromesClinical thrombotic eventsPhysiological hemostasisRisk of bleedingPrevention of thrombosisFXIa inhibitorsBleeding riskReceptor blockersThrombotic eventsAntiplatelet therapyPlatelet antagonistsAntithrombotic efficacyFXIa inhibitionThrombosisExperimental thrombosisPatientsElevated riskLiterature searchAnticoagulationLarge-scale studiesFXIaAssessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis
Harrington J, Hellkamp A, Mahaffey K, Breithardt G, Halperin J, Hankey G, Becker R, Nessel C, Berkowitz S, Fox K, Singer D, Goodman S, Patel M, Piccini J. Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal Of The American Heart Association 2024, 13: e028951. PMID: 38780169, PMCID: PMC11255646, DOI: 10.1161/jaha.122.028951.Peer-Reviewed Original ResearchAtrial fibrillationROCKET AFClinical trialsEnd pointsLow overall event ratesInternational double-blindClinical trials of interventionsRandomized clinical trialsAssessment of dayOverall event rateDouble-blindAnticoagulation trialsTreatment armsIncreased riskWarfarinTrials of interventionsClinical utilityTreatment groupsEvent ratesPatientsDAOHPoisson regressionComorbiditiesFibrillationTrials
Clinical Care
Overview
Clinical Specialties
Radiology & Biomedical Imaging
Board Certifications
Diagnostic Radiology
- Certification Organization
- AB of Radiology
- Original Certification Date
- 1984
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.